Literature DB >> 7727437

Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation.

S Li1, T H Nguyen, C Schöneich, R T Borchardt.   

Abstract

The interactions of proteins with reactive oxygen species may result in covalent modifications of amino acid residues in proteins and possible alterations of protein conformation. In an attempt to elucidate the mechanisms of the metal-catalyzed oxidation of human relaxin, we employed ascorbic acid/transition metal ion [Cu(II) or Fe(III)]/O2 as a model oxidizing system. Experimental results indicated selective oxidation of His and Met residues and rapid formation of aggregates (noncovalent, pH dependent) following the oxidation reaction. Amino acid analysis and LC/MS data following tryptic digestion demonstrated the oxidation of the His A(12) residue, which resulted in 2-oxohistidine and some other unidentified degradation products. The oxidation of both Met residues to Met-sulfoxides was also identified, and it was found that Met B(4) was more easily oxidized than Met B(25). The comparative kinetic studies of two Met-containing fragments of relaxin suggested that the preferred oxidation of Met B(4) is due to its close proximity to some metal-binding neighboring amino acid residues. These covalent alterations may lead to the modification of secondary and tertiary structure and increase the exposure of the hydrophobic surface of the protein which eventually induces aggregation of precipitation. The modification of relaxin by ascorbic acid/CuCl2 solution could be totally inhibited by the presence of EDTA. In contrast, catalase and superoxide dismutase showed no effects on the oxidation process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7727437     DOI: 10.1021/bi00017a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.

Authors:  Shuxia Zhou; Brad Evans; Christian Schöneich; Satish K Singh
Journal:  AAPS PharmSciTech       Date:  2012-01-13       Impact factor: 3.246

2.  2-Oxo-histidine-containing dipeptides are functional oxidation products.

Authors:  Hideshi Ihara; Yuki Kakihana; Akane Yamakage; Kenji Kai; Takahiro Shibata; Motohiro Nishida; Ken-Ichi Yamada; Koji Uchida
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  Chemical pathways of peptide degradation. X: effect of metal-catalyzed oxidation on the solution structure of a histidine-containing peptide fragment of human relaxin.

Authors:  M Khossravi; R T Borchardt
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

4.  Chemical modifications in therapeutic protein aggregates generated under different stress conditions.

Authors:  Quanzhou Luo; Marisa K Joubert; Riki Stevenson; Randal R Ketchem; Linda O Narhi; Jette Wypych
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 5.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

6.  Oxidative degradation of antiflammin 2.

Authors:  J M Ye; J L Wolfe
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

7.  Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.

Authors:  Suzanne Hermeling; Liliana Aranha; J Mirjam A Damen; Monique Slijper; Huub Schellekens; Daan J A Crommelin; Wim Jiskoot
Journal:  Pharm Res       Date:  2005-10-03       Impact factor: 4.200

8.  Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.

Authors:  E M Moussa; J Kotarek; J S Blum; E Marszal; E M Topp
Journal:  Pharm Res       Date:  2016-04-01       Impact factor: 4.200

Review 9.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

10.  Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.

Authors:  Riccardo Torosantucci; Victor S Sharov; Miranda van Beers; Vera Brinks; Christian Schöneich; Wim Jiskoot
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.